Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension (PAH) is a rare condition characterized by high blood pressure in the arteries that supply the lungs, which can lead to symptoms like shortness of breath, fatigue, and chest pain.
Pulmonary Arterial Hypertension: Seralutinib Inhalation Study
We are studying whether inhaling seralutinib helps improve exercise capacity in people with pulmonary arterial hypertension. The trial also looks at safety and other health benefits compared to a placebo.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 75 years old?
- Do you have pulmonary arterial hypertension (PAH)?
- Are you currently pregnant or breastfeeding?
- Are you taking blood thinners like Warfarin, Eliquis, or Xarelto?
- Do you have uncontrolled high blood pressure (systolic over 160 mm Hg or diastolic over 100 mm Hg)?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Gb002
Seralutinib
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Ordensklinikum Linz GmbH
Cardiology, Angiology, Intensive Care Med
Linz, Austria
Medical University of Vienna
Internal Medicine II – Cardiology
Vienna, Austria
UZ Leuven
Pulmonology
Heverlee, Belgium
Sponsor: GB002 Inc.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.